You may remember that last year we shared a video interview with FinThrive talking about a new RCM technology adoption model that they had put together and were sharing with the industry at HFMA. …
Continue Reading
You may remember that last year we shared a video interview with FinThrive talking about a new RCM technology adoption model that they had put together and were sharing with the industry at HFMA. …
Continue Reading
Making well-informed decisions is very important in the healthcare space, especially for areas that are necessary for your organization to function, like revenue cycle management (RCM). The best way to make sure that we…
Continue Reading
Healthcare providers’ finances may be looking more stable in 2024 than they have in recent years, but these organizations are still under a significant amount of pressure from ever-increasing costs, particularly for labor and…
Continue Reading
One of the leading causes of burnout in the healthcare industry is the overwhelming amount of tasks that need to be completed without nearly enough time to do them. And unfortunately, this is a…
Continue Reading
After 10x Revenue Growth in 2023, a Funding Round Led by Threshold will Enable Freshpaint to Expand the Reach and Capabilities of its Category-Creating Software
Today Freshpaint, the Healthcare Privacy Platform creator, announced a $30.7…
Throughout my career in healthcare IT, I’ve seen the unintended consequences that can be found with the implementation of new technologies. As an example, we can look at EHRs and how they made it…
Continue Reading
AI for Revenue Cycle Management (RCM) is hot topic right now. Are we heading for a day when RCM will be completely automated? Is that the path we are on and if so, is…
Continue Reading
Steve Rowe, Healthcare Lead at 3Pillar Global Submitting and paying claims is the financial underpinning of the U.S. healthcare system, a system plagued with inefficiencies that create disconnects between health plans and health systems….
Continue Reading
Top News
Teladoc Health reports Q2 results: revenue down 2%, EPS –$4.92 versus –$0.40, beating Wall Street expectations for earnings but falling short on revenue.
News of the company’s nearly billion-dollar quarterly loss sent shares…
